Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.14% Nasdaq Up 0.02%
Streaming
Ticker Tape: On

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
6.20 Down 0.10(1.59%) 12:00PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:6.30
Open:6.27
Bid:6.21 x 3500
Ask:6.22 x 5800
1y Target Est:7.83
Beta:-2.3
Next Earnings Date:N/A
Day's Range:6.16 - 6.33
52wk Range:4.05 - 9.25
Volume:1,764,999
Avg Vol (3m):5,741,720
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 1.59%1.36B
GSKDown 0.51%125.89B
OREXDown 2.23%586.69M
RHHBYDown 0.17%122.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Mar-14) :-0.10
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback